CALT - Calliditas Therapeutics AB Sponsored ADR - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

CALT is currently covered by 1 analysts with an average potential upside of $21.72 (107.09%) backed by displayed 0 price targets and 2 ratings.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 44.44% with an average time for these price targets to be met of 40.67 days.

Highest price target for CALT is 20, Lowest price target is 16, average price target is 18.

Most recent stock forecast was given by VAMIL DIVAN from GUGGENHEIM on 18-Aug-2023. First documented stock forecast 17-Dec-2021.

Best performing analysts who are covering CALT - Calliditas Therapeutics AB Sponsored ADR:

Annabel Samimy Yigal Nochomovitz Vamil Divan

Currently, out of the existing stock ratings of CALT - 2 which are a Hold (100%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Hold

18

$-0.26 (-1.42%)

18

3 months 11 days ago

2/2 (100%)

$0.05 (1.04%)

21

Buy

74

$56.54 (323.83%)

79

6 months 12 days ago

0/4 (0%)

$58.26 (296.50%)

Buy

42

$26.51 (171.14%)

38

2 years 9 months 11 days ago

1/3 (33.33%)

$6.85 (23.74%)

101

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CALT (Calliditas Therapeutics AB Sponsored ADR) average time for price targets to be met?

On average it took 40.67 days on average for the stock forecasts to be realized with a an average price target met ratio 44.44

Which analyst has the current highest performing score on CALT (Calliditas Therapeutics AB Sponsored ADR) with a proven track record?

ANNABEL SAMIMY

Which analyst has the current lower performing score on CALT (Calliditas Therapeutics AB Sponsored ADR) with a proven track record?

VAMIL DIVAN

Which analyst has the most public recommendations on CALT (Calliditas Therapeutics AB Sponsored ADR)?

Annabel Samimy works at STIFEL and has 3 price targets and 4 ratings on CALT

Which analyst is the currently most bullish on CALT (Calliditas Therapeutics AB Sponsored ADR)?

Yigal Nochomovitz with highest potential upside - $56.54

Which analyst is the currently most reserved on CALT (Calliditas Therapeutics AB Sponsored ADR)?

Vamil Divan with lowest potential downside - -$0.26

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart